144 related articles for article (PubMed ID: 37401632)
21. Disorders of hyperpigmentation. Part II. Review of management and treatment options for hyperpigmentation.
Ko D; Wang RF; Ozog D; Lim HW; Mohammad TF
J Am Acad Dermatol; 2023 Feb; 88(2):291-320. PubMed ID: 35158001
[TBL] [Abstract][Full Text] [Related]
22. A comparative study between oral tranexamic acid versus oral tranexamic acid and Q-switched Nd-YAG laser in melasma treatment: a clinical and dermoscopic evaluation.
Agamia N; Apalla Z; Salem W; Abdallah W
J Dermatolog Treat; 2021 Nov; 32(7):819-826. PubMed ID: 31908179
[TBL] [Abstract][Full Text] [Related]
23. Riehl's melanosis.
rorsman H
Int J Dermatol; 1982 Mar; 21(2):75-8. PubMed ID: 7068304
[TBL] [Abstract][Full Text] [Related]
24. Comparison of efficacy and safety of tranexamic acid mesotherapy versus oral tranexamic acid in patients with melasma undergoing Q-switched fractional 1064-nm Nd:YAG laser: A blinded RCT and follow-up.
Behrangi E; Shemshadi M; Ghassemi M; Goodarzi A; Dilmaghani S
J Cosmet Dermatol; 2022 Jan; 21(1):279-289. PubMed ID: 34724323
[TBL] [Abstract][Full Text] [Related]
25. [An exceptionally intense and still progressive evolution of Riehl's melanosis; Coexistence of Riehl's melanosis in the patient's mother].
MICHEL PJ; SAINT-PAUL J
Lyon Med; 1948 Feb; 179(5):87. PubMed ID: 18909689
[No Abstract] [Full Text] [Related]
26. Therapeutic hotline. The effectiveness of intense pulsed light for possible Riehl's melanosis.
Oiso N; Tsuruta D; Imanishi H; Hirao A; Wada T; Sasaya H; Kobayashi H; Kawada A
Dermatol Ther; 2010; 23(5):561-3. PubMed ID: 20882711
[No Abstract] [Full Text] [Related]
27. Coexistence of Riehl's melanosis and lichen planus.
Seike M; Hirose Y; Ikeda M; Kodama H
J Dermatol; 2003 Feb; 30(2):132-4. PubMed ID: 12692380
[TBL] [Abstract][Full Text] [Related]
28. Melasma: A critical analysis of clinical trials investigating treatment modalities published in the past 10 years.
Spierings NMK
J Cosmet Dermatol; 2020 Jun; 19(6):1284-1289. PubMed ID: 31603285
[TBL] [Abstract][Full Text] [Related]
29. Treatment of melasma with mixed parameters of 1,064-nm Q-switched Nd:YAG laser toning and an enhanced effect of ultrasonic application of vitamin C: a split-face study.
Lee MC; Chang CS; Huang YL; Chang SL; Chang CH; Lin YF; Hu S
Lasers Med Sci; 2015 Jan; 30(1):159-63. PubMed ID: 25073866
[TBL] [Abstract][Full Text] [Related]
30. The efficacy in treatment of facial melasma with thulium 1927-nm fractional laser-assisted topical tranexamic acid delivery: a split-face, double-blind, randomized controlled pilot study.
Wanitphakdeedecha R; Sy-Alvarado F; Patthamalai P; Techapichetvanich T; Eimpunth S; Manuskiatti W
Lasers Med Sci; 2020 Dec; 35(9):2015-2021. PubMed ID: 32506227
[TBL] [Abstract][Full Text] [Related]
31. A prospective randomized controlled trial of Q-switched Nd:YAG laser with topical 3% tranexamic acid (TA) versus microneedling with topical 3% tranexamic acid (TA) in treatment of melasma.
Debasmita B; Raj C; Ishan A; Ipsita D
J Cosmet Dermatol; 2022 Jul; 21(7):2801-2807. PubMed ID: 34636493
[TBL] [Abstract][Full Text] [Related]
32. A split-face, investigator-blinded comparative study on the efficacy and safety of Q-switched Nd:YAG laser plus microneedling with vitamin C versus Q-switched Nd:YAG laser for the treatment of recalcitrant melasma.
Ustuner P; Balevi A; Ozdemir M
J Cosmet Laser Ther; 2017 Nov; 19(7):383-390. PubMed ID: 28657378
[TBL] [Abstract][Full Text] [Related]
33. Coexistence of Riehl's Melanosis, Lupus Erythematosus and Thyroiditis in a Patient.
Lai K; Zheng X; Wei S; Zhou H; Zeng X; Liang G; Zhang Z; Zhang W
Clin Cosmet Investig Dermatol; 2022; 15():1809-1813. PubMed ID: 36105748
[TBL] [Abstract][Full Text] [Related]
34. [Riehl's disease].
Solduga Caltells F; Noguer Debray S; Ripoll M
Actas Dermosifiliogr; 1965; 56(11):344-8. PubMed ID: 5874757
[No Abstract] [Full Text] [Related]
35. Oral tranexamic acid, hydroquinone 4% and low-fluence 1064 nm Q-switched Nd:YAG laser for mixed melasma: Clinical and dermoscopic evaluation.
Elkamshoushi AM; Romisy D; Omar SS
J Cosmet Dermatol; 2022 Feb; 21(2):657-668. PubMed ID: 33826785
[TBL] [Abstract][Full Text] [Related]
36. Laser-assisted delivery of tranexamic acid for melasma: Pilot study using a novel 1927 nm fractional thulium fiber laser.
Wang JV; Christman MP; Feng H; Ferzli G; Jeon H; Geronemus RG
J Cosmet Dermatol; 2021 Jan; 20(1):105-109. PubMed ID: 33174686
[TBL] [Abstract][Full Text] [Related]
37. Melasma and Post Inflammatory Hyperpigmentation: Management Update and Expert Opinion.
Sofen B; Prado G; Emer J
Skin Therapy Lett; 2016 Jan; 21(1):1-7. PubMed ID: 27224897
[TBL] [Abstract][Full Text] [Related]
38. [Riehl's melanosis; is there a melanodermy of hydrocarbons and tars?].
JOULIA ; LE COULANT ; L'EPREE
Med Usine Rev Hyg Ind Mal Prof; 1948 Jun; 10(6):272-4. PubMed ID: 18867801
[No Abstract] [Full Text] [Related]
39. The efficacy of energy-based devices combination therapy for melasma.
Iranmanesh B; Khalili M; Mohammadi S; Amiri R; Aflatoonian M
Dermatol Ther; 2021 May; 34(3):e14927. PubMed ID: 33665885
[TBL] [Abstract][Full Text] [Related]
40. Comparative study of fractional Erbium: YAG laser vs combined therapy with topical steroid as an adjuvant treatment in melasma.
Abdel-Raouf Mohamed H; Ali Nasif G; Saad Abdel-Azim E; Abd El-Fatah Ahmed M
J Cosmet Dermatol; 2019 Apr; 18(2):517-523. PubMed ID: 30146730
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
